A detailed history of First Bank & Trust transactions in Elevance Health, Inc. stock. As of the latest transaction made, First Bank & Trust holds 746 shares of ELV stock, worth $298,914. This represents 0.08% of its overall portfolio holdings.

Number of Shares
746
Previous 705 5.82%
Holding current value
$298,914
Previous $382,000 1.31%
% of portfolio
0.08%
Previous 0.08%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$500.12 - $562.29 $20,504 - $23,053
41 Added 5.82%
746 $387,000
Q2 2024

Jul 09, 2024

BUY
$497.49 - $547.8 $8,457 - $9,312
17 Added 2.47%
705 $382,000
Q1 2024

Apr 17, 2024

BUY
$464.61 - $519.96 $17,655 - $19,758
38 Added 5.85%
688 $356,000
Q4 2023

Jan 12, 2024

BUY
$433.51 - $488.06 $34,247 - $38,556
79 Added 13.84%
650 $306,000
Q2 2023

Jul 12, 2023

SELL
$436.33 - $496.2 $28,797 - $32,749
-66 Reduced 10.36%
571 $253,000
Q1 2023

Apr 25, 2023

SELL
$446.3 - $502.2 $16,066 - $18,079
-36 Reduced 5.35%
637 $292,000
Q4 2022

Jan 27, 2023

BUY
$465.23 - $546.77 $9,304 - $10,935
20 Added 3.06%
673 $345,000
Q3 2022

Oct 28, 2022

BUY
$445.98 - $507.0 $19,623 - $22,308
44 Added 7.22%
653 $297,000
Q2 2022

Jul 22, 2022

BUY
$444.32 - $529.84 $19,550 - $23,312
44 Added 7.79%
609 $294,000
Q1 2022

Apr 29, 2022

BUY
$428.44 - $502.48 $16,280 - $19,094
38 Added 7.21%
565 $278,000
Q4 2021

Feb 01, 2022

BUY
$370.08 - $467.67 $4,811 - $6,079
13 Added 2.53%
527 $244,000
Q3 2021

Oct 18, 2021

BUY
$357.51 - $398.13 $8,580 - $9,555
24 Added 4.9%
514 $192,000
Q2 2021

Aug 10, 2021

BUY
$352.19 - $401.9 $13,383 - $15,272
38 Added 8.41%
490 $187,000
Q1 2021

Apr 14, 2021

BUY
$287.7 - $371.31 $18,412 - $23,763
64 Added 16.49%
452 $162,000
Q4 2020

Jan 27, 2021

SELL
$270.17 - $333.15 $4,592 - $5,663
-17 Reduced 4.2%
388 $125,000
Q3 2020

Oct 26, 2020

BUY
$245.73 - $284.63 $4,177 - $4,838
17 Added 4.38%
405 $109,000
Q2 2020

Aug 05, 2020

BUY
$203.3 - $300.59 $3,659 - $5,410
18 Added 4.86%
388 $102,000
Q1 2020

Apr 14, 2020

SELL
$174.68 - $307.74 $2,096 - $3,692
-12 Reduced 3.14%
370 $84,000
Q4 2019

Jan 31, 2020

BUY
$234.82 - $306.42 $5,166 - $6,741
22 Added 6.11%
382 $115,000
Q3 2019

Oct 17, 2019

SELL
$237.69 - $310.48 $713 - $931
-3 Reduced 0.83%
360 $86,000
Q2 2019

Jul 26, 2019

BUY
$236.25 - $293.76 $11,576 - $14,394
49 Added 15.61%
363 $102,000
Q1 2019

Apr 15, 2019

SELL
$248.42 - $317.42 $11,675 - $14,918
-47 Reduced 13.02%
314 $90,000
Q4 2018

Jan 28, 2019

BUY
$249.0 - $296.25 $12,450 - $14,812
50 Added 16.08%
361 $95,000
Q2 2018

Jul 31, 2018

BUY
$220.13 - $245.16 $20,912 - $23,290
95 Added 43.98%
311 $74,000
Q4 2017

Jan 18, 2018

SELL
$183.76 - $234.96 $10,290 - $13,157
-56 Reduced 20.59%
216 $49,000
Q3 2017

Oct 25, 2017

BUY
$181.44 - $197.43 $49,351 - $53,700
272
272 $52,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.2B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track First Bank & Trust Portfolio

Follow First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.